Dysfunction prediction model employs statistical algorithms forecasting organ system impairment affecting drug metabolism. Renal dysfunction develops progressively from chronic kidney disease. Hepatic dysfunction results from cirrhosis or fibrosis. Cardiac dysfunction compromises haemodynamics. Predictive biomarkers identify early dysfunction enabling intervention.
Risk stratification informs treatment selection. Dose adjustments prevent toxicity in dysfunctional patients. Therapeutic drug monitoring guides individualised dosing. Regulatory submissions incorporate dysfunction considerations. Post-approval monitoring identifies unexpected dysfunction patterns.
General Biopharmaceutical Concepts
Dysfunction Prediction Model
A dysfunction prediction model uses biological, clinical or computational data to estimate the likelihood of disease progression or functional impairment.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →